Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Boxer Capital Management, LLC
Form 13F · Q2 2026

Boxer Capital Management, LLC

CIK 2018299申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$13.3亿
申报组合市值
63
持仓数量
7
Quarters on record
Top 50
持仓数量

Boxer Capital Management, LLC——持仓

共 63 个持仓中的前 50 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1TNGX Tango Therapeutics Inc10.9M+0.0%$3.4亿25.6%
2RVMD Revolution Medicines Inc500,000+0.0%$9364万7.1%
3ABIVAX SA Abivax Sa605,000+202.5%$8062万6.1%
4UNIQURE NV Uniqure Nv1.5M+127.1%$6924万5.2%
5KOD Kodiak Sciences Inc1.5M+8.6%$5757万4.3%
6KYMR Kymera Therapeutics Inc429,100+30.4%$4920万3.7%
7DFTX Definium Therapeutics Inc998,500+66.8%$4697万3.5%
8REPL Replimune Group Inc4.0M+239.0%$4409万3.3%
9CELC Celcuity Inc416,530+85.1%$4358万3.3%
10QTTB Q32 Bio Inc3.1M—$4012万3.0%
11CAPR Capricor Therapeutics Inc1.4M+136.5%$3360万2.5%
12PGEN Precigen Inc5.2M+47.1%$2936万2.2%
13CORT Corcept Therapeutics Inc335,500+34.2%$2917万2.2%
14SRZN Surrozen Inc1.1M+44.3%$2696万2.0%
15PTGX Protagonist Therapeutics Inc170,000+0.0%$2084万1.6%
16VIR Vir Biotechnology Inc1.9M+0.0%$1901万1.4%
17PCVX Vaxcyte Inc325,000+0.0%$1889万1.4%
18URGN Urogen Pharma Ltd500,000+0.0%$1840万1.4%
19CRVS Corvus Pharmaceuticals Inc1.1M+0.0%$1643万1.2%
20PTCT Ptc Therapeutics Inc200,000+0.0%$1631万1.2%
21PRAX Praxis Precision Medicines I46,457+0.0%$1555万1.2%
22AMLX Amylyx Pharmaceuticals Inc800,000+0.0%$1437万1.1%
23OCUL Ocular Therapeutix Inc1.3M+271.4%$1277万1.0%
24IRD Opus Genetics Inc2.8M+25.1%$1157万0.9%
25PALI Palisade Bio Inc4.8M+0.0%$1003万0.8%
26APOGEE THERAPEUTICS INC Apogee Therapeutics Inc70,000+0.0%$929万0.7%
27SYRE Spyre Therapeutics Inc100,000—$888万0.7%
28COGT Cogent Biosciences Inc225,000+0.0%$871万0.7%
29CYTK Cytokinetics Inc100,000+0.0%$852万0.6%
30RLAY Relay Therapeutics Inc450,000—$842万0.6%
31CBIO Crescent Biopharma Inc.453,686+0.0%$817万0.6%
32CTNM Contineum Therapeutics Inc494,000+0.0%$810万0.6%
33KZIA Kazia Therapeutics Ltd560,000—$788万0.6%
34STTK Shattuck Labs Inc1.0M—$694万0.5%
35AVTX Avalo Therapeutics Inc375,000+25.0%$693万0.5%
36FORTE BIOSCIENCES INC Forte Biosciences Inc274,500—$583万0.4%
37RLMD Relmada Therapeutics Inc842,106+0.0%$583万0.4%
38MLTX Moonlake Immunotherapeutics275,000+0.0%$535万0.4%
39ZURA Zura Bio Ltd900,000+0.0%$531万0.4%
40CYBIN INC Cybin Inc790,000+23.4%$522万0.4%
41ODTX Odyssey Therapeutics Inc275,000—$515万0.4%
42IMTX Immatics N.V475,000—$481万0.4%
43FTH Faeth Therapeutics Inc180,505—$451万0.3%
44GPCR Structure Therapeutics Inc75,000+0.0%$403万0.3%
45ORIC Oric Pharmaceuticals Inc350,000+98.3%$379万0.3%
46ANTX An2 Therapeutics Inc749,035+0.0%$363万0.3%
47NMRA Neumora Therapeutics Inc.2.0M—$340万0.3%
48INO Inovio Pharmaceuticals Inc2.8M+20.0%$313万0.2%
49ALLO Allogene Therapeutics Inc1.5M−45.0%$312万0.2%
50SLDB Solid Biosciences Inc300,000+0.0%$300万0.2%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。